The Weekly Update

The Stratton Street Team would like to wish all our readers a very happy and prosperous 2018.

An interesting couple of weeks has followed our last weekly report, we’ve had: Jong-Un and Trump gloat about the location and size of their nuclear buttons, clashes in Iran, broadly stronger PMI and ISM numbers, signs of a pick-up in global growth, a record breaking US equity market, US yield curve flattening, renminbi appreciation, and of course the US tax “legislative victory”; amongst other events.

Last week we heard from the FOMC following the committee’s meeting in December (where the central bank hiked rates by 25bps to 1.25%-1.50%). There appeared to be mixed feelings about inflation, with recent readings showing a pick-up in prices of goods and services, some members argued that inflation may remain below the central bank target for some time. Meanwhile, others warned of the possibilities that increased output resulting from recent “fiscal stimulus or accommodative financial market conditions” could, in fact, cause inflation to spike. On the recently passed tax bill, a number of participants judged that business taxes “would likely provide a modest boost to capital spending, although the magnitude of the effects was uncertain”. There was also a mention, that although the labour market remains strong, “wage increases has generally been modest”; on Friday average hourly earnings for December were in-line with expectations at 2.5% yoy. Overall, most participants maintained their view for “continuing a gradual approach to raising the target range” (three rate hikes for 2018 are currently priced in, with the next hike expected in March).

Broadly stronger US data, including a stronger-than-expected ISM manufacturing reading saw a bounce in the dollar, which eventually lost its footing following the FOMC’s “gradual” comment, and weaker-than-expected non-farm payroll and ISM composite prints. Meanwhile, the yield on the 10-year US Treasury sold-off 7bps, closing the week at 2.477%. This week we’ll get the JOLTS job openings report on Tuesday. Import and export price indexes follow on Wednesday, where the month-on-month readings are expected to have dropped in December, from previous levels. Thursday will see December’s PPI releases, and December’s monthly budget statement, and the week ends with CPI prints (headline number expected at 2.1% in December) and retail sales readings (expected to have weakened in December from previous levels).

Elsewhere, the renminbi maintained its stronger trend against the dollar, gaining 0.55% over the week. With the renminbi breaking through the 6.50 level last week it is clear that policymakers are unfazed by its appreciation, and a stronger renminbi could help stem capital outflow. Meanwhile, Caixin PMI readings for China surprised to the upside in December. During China’s Central Economic Work Conference - where policy and forecasts were set for 2018 - there was an emphasis placed on “high quality growth”, at the expense of faster pace of expansion; it was very apparent that policymakers would tolerate slower growth going forward. Although no growth target was mentioned at the conference, according to sources, at a closed-door meeting during the event top leaders agreed to keep the target at “around 6.5 percent”. The pick-up in global growth will no doubt support China's economic expansion. In terms of data, this week we’ll see China’s PPI and CPI prints and trade numbers for December.

Also this week, the two Koreas are expected to hold talks for the first time since 2015 tomorrow. Ahead of that PM Theresa May will begin the process of reshuffling her cabinet. We will also see the ongoing coalition discussions in Germany, and France's Macron visit to China could garner some interest. On Wednesday, South Korean President Jae-In will host a New Year conference where the likes of North Korea, and relationships with China and the US are expected to be discussed. 2017 growth estimates for Germany could be of interest on Thursday, as could the ECB’s December meeting notes release. Also on Thursday, China is due to commence its three-day annual plenary meeting, where it will set the agenda for its anti-corruption campaign for the year. Mr. Trump's first medical examination by a government doctor will take place on Friday; the subsequent official statement on the president’s health could be of interest to some. We will also hear from a number of Fed members later today; discussing Inflation targeting, with others speaking about Monetary Policy and the US Economic Outlook.

Please read this important information before proceeding. It contains legal and regulatory notices relevant to the information on this site.

This website provides information about Stratton Street Capital LLP ("Stratton Street"). Stratton Street is authorised and regulated by the UK's Financial Conduct Authority. The content of this website has been prepared by Stratton Street from its records and is believed to be accurate but we do not accept any liability or responsibility in respect of the information of any views expressed herein. The information, material and content provided in the pages of this website may be changed at any time by us. Information on this website may be out of date and may not be updated or removed.

The website is provided for the main purpose of providing generic information on Stratton Street and on our investment philosophy for the use of financial professionals in the United Kingdom that qualify as Professional Clients or Eligible Counterparties under the rules of the United Kingdom Financial Conduct Authority (the "FCA"). The information in this website is not intended for the use of and should not be relied on by any person who would qualify as a Retail Client. Products and services referred to on this website are offered only at times when, and in jurisdictions where, they may be lawfully offered. The information on this website is not directed to any person in the United States. The provision of the information on this website does not constitute an offer to purchase securities to any person in the United States (other than a professional fiduciary acting for the account of a non-U.S person) or to any U.S. person as such term is defined under the Securities Act of 1933, as amended.

The website is not intended to offer investors the opportunity to invest in any Alternative Investment Fund ("AIF") product. The AIFs managed by Stratton Street are not being marketed in the European Economic Area ("EEA") and any eligible potential investor from the EEA who wishes to obtain information on the AIFs will only be provided with materials upon receipt by Stratton Street of an appropriate reverse solicitation request in accordance with the requirements of the EU Alternative Investment Fund Managers Directive ("AIFMD") and national law in their home jurisdiction. By proceeding you confirm that you are not accessing this website in the context of a potential investment by an EEA investor in the AIFs managed by Stratton Street and that you have read, understood and agree to these terms.

No information contained in this website should be deemed to constitute the provision of financial, investment or other professional advice in any way. The website should not be relied upon as including sufficient information to support any investment decision. If you are in doubt as to the appropriate course of action we recommend that you consult your own independent financial adviser, stockbroker, solicitor, accountant or other professional adviser. Past performance is not necessarily a guide to the future. The value of investments and the income from them may go down as well as up. An application for any investment or service referred to on this site may only be made on the basis of the offer document, key features, prospectus or other applicable terms relating to the specific investment or service.

Where we provide hypertext links to other locations on the Internet, we do so for information purposes only. We are not responsible for the content of any other websites or pages linked to or linking to this website. We have not verified the content of any such websites. Such websites may contain products and services that are not authorised in your jurisdiction. Following links to any other websites or pages shall be at your own risk and we shall not be responsible or liable for any damages or in other way in connection with linking.

By using this site, you should be aware that we may disclose any information that we hold about you to any regulatory authority to which we are subject, or to any person legally empowered to require such information.

This website uses cookies to improve user experience, by clicking the "I Accept" button below means you consent to the use of cookies on our website.